Tag: process

MELBOURNE, Australia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lumen has launched “The Talent Frontier,” a webcast series exploring innovative recruitment marketing and talent acquisition strategies to transform hiring. The inaugural session “AI for All: Rethinking Talent with Equity, Empathy & Automation,” sets the stage for diverse and inclusive topics in future sessions.

ROK Financial reports rising interest in flexible business lines of credit as small and mid-sized companies seek faster, more adaptable funding options in 2025.

Public interest in vitamin C has surged in 2025 as consumers search for cleaner, more effective options beyond standard pills. Across TikTok, Reddit, and wellness forums, questions are rising about ingredient sources, absorption rates, and the difference between synthetic ascorbic acid and real, whole-food vitamin C. NativePath Liposomal Vitamin C is positioned within this growing trend, featuring an amla-based 3-in-1 formula designed for nutrient integrity and advanced delivery. It reflects a broader shift toward transparency, clean sourcing, and solutions that align with evolving health and wellness priorities.

CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Acceleware^® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine regeneration (for carbon capture and other applications), and enhanced oil production, is pleased to announce that further to its news release dated June 30, 2025, the Company has closed certain shares for debt transactions to settle $186,337 in certain trades payable, management fees and interest payable on convertible debentures of the Company by issuing up to 1,863,375 Units at a deemed price of $0.10 per Unit (the “Shares for Debt Transactions”).

Fast, flexible funding options help businesses nationwide acquire essential equipment while preserving cash flow and supporting long-term growth.

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.

Date: Monday, August 18, 2025

Conference call to follow tomorrow, August 14 at 5 PM EST